GRI — GRI BIO INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $0 | — | -$6.5M | — | -73.9% | — | — | — | — | — | — |
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -0.82 | — | -0.73 | -0.91 | 2 | +1 |
| Mar 2027 | -0.98 | — | -0.98 | -0.98 | 1 | — |
| Jun 2027 | -0.96 | — | -0.96 | -0.96 | 1 | — |
| Sep 2027 | -0.94 | — | -0.94 | -0.94 | 1 | — |
| Dec 2027 | -0.92 | — | -0.92 | -0.92 | 1 | — |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | -3.88 | — | -3.63 | -4.13 | 2 | −1 |
| Dec 2027 | -2.00 | — | -0.20 | -3.79 | 2 | +1 |
| Dec 2028 | -0.16 | — | -0.16 | -0.16 | 1 | +1 |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 12 SEC-registered investment managers reported holding GRI (GRI BIO INC) in their latest 13F filings, with a combined reported value of $228.12K across 118.69K shares. That is +7.7% by share count (+6.20K shares) versus the previous quarter, while reported value moved +17.6%. Ownership is concentrated: the five largest holders account for 90.6% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 3 opened new positions, 2 added to existing stakes, 3 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of GRI BIO INC (GRI) include Altium Capital Management LLC, ARMISTICE CAPITAL, LLC, JANE STREET GROUP, LLC, ranked by reported 13F value among the 27 institutional holders on this page.
GRI is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 12 | 118.69K | $228.12K | +7.7% |
| Q2 2026 | 12 | 107.45K | $189.24K | -24.8% |
| Q1 2026 | 6 | 28.23K | $64.65K | -26.0% |
| Q4 2025 | 7 | 59.64K | $14.72K | +28.6% |
| Q3 2025 | 7 | 33.77K | $69.57K | -77.6% |
| Q2 2025 | 5 | 19.64K | $25.33K | +304.9% |
| Q1 2025 | 5 | 4.85K | $15.52K | -95.2% |
| Q4 2024 | 8 | 223.85K | $185.23K | +91.8% |
Over the 8 quarters shown, institutional share counts decreased 47% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (+304.9%).
Top Institutional Holders (Q3 2026) — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 30.72K | $59.29K | 0.00% | New | |
| 26.40K | $50.00K | 0.00% | Reduce | |
| 21.37K | $41.24K | 0.00% | Hold | |
| 19.03K | $36.73K | 0.00% | Add | |
| 10.04K | $19.39K | 0.00% | Reduce | |
| 8.74K | $16.86K | 0.00% | Hold | |
| 1.65K | $3.17K | 0.00% | New | |
| 731 | $1.41K | 0.00% | Reduce | |
| 7 | $14 | 0.00% | Hold | |
| 3 | $6 | 0.00% | Add | |
| 2 | $4 | 0.00% | Hold | |
| 2 | $4 | 0.00% | New |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 12 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 28.78K | $50.00K | 0.00% | New | |
| 21.37K | $37.82K | 0.00% | New | |
| 13.87K | $24.55K | 0.00% | New | |
| 13.87K | $24.55K | 0.00% | Reduce | |
| 13.38K | $23.68K | 0.00% | New | |
| 8.74K | $15.46K | 0.00% | New | |
| 4.92K | $8.71K | 0.00% | Reduce | |
| 2.43K | $4.31K | 0.00% | Add | |
| 83 | $147 | 0.00% | New | |
| 7 | $12 | 0.00% | Hold | |
| 2 | $4 | 0.00% | New | |
| 2 | $4 | 0.00% | Hold |
Q1 2026 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 18.44K | $42.22K | 0.00% | Reduce | |
| 8.72K | $19.97K | 0.00% | New | |
| 1.06K | $2.43K | 0.00% | Reduce | |
| 7 | $16 | 0.00% | Reduce | |
| 4 | $9 | 0.00% | Reduce | |
| 2 | $5 | 0.00% | New |
Q4 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 23.18K | $5.72K | 0.00% | Add | |
| 17.00K | $4.20K | 0.00% | Hold | |
| 16.25K | $4.01K | 0.00% | New | |
| 2.85K | $704 | 0.00% | Reduce | |
| 211 | $52 | 0.00% | Hold | |
| 117 | $29 | 0.00% | Hold | |
| 23 | $5 | 0.00% | Add |
Q3 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 17.00K | $35.02K | 0.00% | New | |
| 12.37K | $25.48K | 0.00% | New | |
| 4.02K | $8.29K | 0.00% | Add | |
| 211 | $435 | 0.00% | Hold | |
| 117 | $241 | 0.00% | Hold | |
| 27 | $56 | 0.00% | Reduce | |
| 22 | $45 | 0.00% | Add |
Q2 2025 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 15.46K | $19.94K | 0.00% | Add | |
| 3.83K | $4.95K | 0.00% | Add | |
| 211 | $272 | 0.00% | Hold | |
| 117 | $151 | 0.00% | Hold | |
| 19 | $25 | 0.00% | Add |
New Positions (Q3 2026)
- JANE STREET GROUP, LLC 30.72K sh · $59.29K
- Citigroup Inc 1.65K sh · $3.17K
- Robinhood Markets, Inc. 2 sh · $4
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 13.87K sh · $24.55K
- Citadel Advisors sold 13.38K sh · $23.68K
- BARCLAYS PLC sold 83 sh · $147
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | 30.72K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 26.40K | 28.78K | — | — | — | — | — | — | 13.96K | — | 19.51K | 23.98K | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 21.37K | 21.37K | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 19.03K | 4.92K | 8.72K | — | 27 | 15.46K | 3.25K | 92.27K | 71.65K | 17.96K | 8.02K | 2.39K | — | 899 |
| Geode Capital Management | 10.04K | 13.87K | 18.44K | 23.18K | 12.37K | — | — | 76.18K | 11.85K | — | — | 14.75K | 14.87K | 14.88K |
| Morgan Stanley | 8.74K | 8.74K | — | — | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | 1.65K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Tower Research Capital LLC (TRC) | 731 | 2.43K | 1.06K | 2.85K | 4.02K | 3.83K | 1.27K | 3.49K | 4.46K | 308 | 6.03K | 6.45K | 7.43K | — |
| BlackRock Inc | 7 | 7 | 7 | 211 | 211 | 211 | 211 | 3.60K | 3.60K | — | — | — | — | — |
| Caitong International Asset Management Co., Ltd | 3 | 2 | — | — | — | — | — | — | — | — | — | — | — | — |
| DANSKE BANK A/S | 2 | 2 | 2 | — | — | — | — | — | — | — | — | — | — | — |
| Robinhood Markets, Inc. | 2 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Altium Capital Management LLC | — | — | — | — | — | — | — | — | — | — | 187.98K | — | 521.51K | — |
| ARMISTICE CAPITAL, LLC | — | — | — | — | — | — | — | — | — | 50.21K | — | — | — | — |
| Vanguard Group | — | — | — | 17.00K | 17.00K | — | — | — | — | — | — | 18.54K | 18.54K | — |
| Citadel Advisors | — | 13.38K | — | — | — | — | — | — | — | — | — | 86.12K | — | — |
| Virtu Financial LLC | — | — | — | — | — | — | — | 30.38K | — | — | — | — | — | — |
| GEODE CAPITAL MANAGEMENT, LLC | — | 13.87K | — | — | — | — | — | — | — | — | — | — | — | — |
| Stratos Wealth Partners, LTD. | — | — | — | — | — | — | — | — | — | — | — | 25.00K | 10.00K | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | — | — | — | 40.00K | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold GRI?
As of 2026-Q3, 12 institutional funds reported holding GRI (GRI BIO INC) in SEC 13F filings, with a combined reported value of $228.12K.
How many shares of GRI do institutions own?
13F filers reported 118.69K shares of GRI, worth $228.12K in aggregate at the end of 2026-Q3.
Is institutional ownership of GRI rising or falling?
Share counts moved +7.7% versus the prior quarter — accumulation.
Who are the top institutional holders of GRI?
The largest 13F holders are Altium Capital Management LLC, ARMISTICE CAPITAL, LLC, JANE STREET GROUP, LLC, HRT FINANCIAL LP, VANGUARD CAPITAL MANAGEMENT LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of GRI BIO INC?
The major shareholders of GRI BIO INC (GRI) by reported 13F value are Altium Capital Management LLC, ARMISTICE CAPITAL, LLC, JANE STREET GROUP, LLC, HRT FINANCIAL LP, VANGUARD CAPITAL MANAGEMENT LLC, among 27 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.